Scientists Can Advance Research By Joining with Patient-Advocacy Groups

Like most Americans who are not scientists, I have been relatively ignorant of how science is conducted and funded until recently. In 1992 I founded a nonprofit organization to help women who have chronic vulvar pain. Directing a grass-roots patient-advocacy organization has brought my attention to the critical lack of funds available for basic research. Although urging scientists to lobby Congress themselves is certainly a reasonable strategy for obtaining more funds, I have a suggestion. Wh

Written byJoanne Yount
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Joanne Yount Like most Americans who are not scientists, I have been relatively ignorant of how science is conducted and funded until recently. In 1992 I founded a nonprofit organization to help women who have chronic vulvar pain. Directing a grass-roots patient-advocacy organization has brought my attention to the critical lack of funds available for basic research.

Although urging scientists to lobby Congress themselves is certainly a reasonable strategy for obtaining more funds, I have a suggestion. Why not join forces with the people who have the most at stake in basic research-those who suffer from disorders whose causes are not fully identified or for which completely effective treatments are not known?

In the United States there are literally hundreds of grass-roots patient-advocacy organizations. They represent thousands of people-sometimes hundreds of thousands of people-who suffer from arthritis, cancer, headaches, trigeminal neuralgia, fibromyalgia, irritable bowel syndrome, chronic fatigue syndrome, and more. Many of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies